Monday, February 8, 2016

J&J might sell its Ortho Clinical Diagnostics division

Johnson & Johnson might sell its Ortho Clinical Diagnostics business if it can find the right price, CEO Alex Gorsky said Tuesday morning.

J&J might sell its Ortho Clinical Diagnostics division

0 comments
Technician at Ortho-Clinical Diagnostics, a J&J unit, in Raritan, N.J. The health-care giant cited a sales slump for heart stents among reasons for cutting costs. It did not say which plants would be affected. (Associated Press)
Technician at Ortho-Clinical Diagnostics, a J&J unit, in Raritan, N.J. The health-care giant cited a sales slump for heart stents among reasons for cutting costs. It did not say which plants would be affected. (Associated Press)

New York - Johnson & Johnson might sell its Ortho Clinical Diagnostics business if it can find the right price, chief executive officer Alex Gorsky said Tuesday morning.

The division has its headquarters in Raritan, N.J., and its research and development center in Rochester, N.Y.

Gorsky said J&J is "initiating the first steps," in the divestiture process of that division.

"When you look at diagnostics, we have good technology and a lot of good businesses, but they are not No. 1 or 2 in the market," Gorsky said.

Gorsky spoke at an investor conference held at the Pierre Hotel to discuss the company's financial results for all of 2012 and the fourth quarter.

A link to Ortho Clinical Diagnostics is here.

Staff Writer
0 comments
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy:

Philly.com comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by Philly.com staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
 
comments powered by Disqus
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at dsell@phillynews.com or 215-854-4506.

David Sell Staff Writer
Also on Philly.com:
letter icon Newsletter